Peng Zhao

RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial

Z. Liu, T. Liang, W. Fang, 2023, EClinicalMedicine.

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment.

Wei Wu, Z. Tong, Yuzhi Jin, 2024, Biomaterials.

A Pathologically Friendly Strategy for Determining the Organ‐specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom‐seq and Imaging Mass Cytometry

Lulu Liu, Yuzhi Jin, Peng Zhao, 2024, Advanced science.

Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor

Tao Sheng, Zhen Gu, Jiaqi Shi, 2024, National science review.

The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient.

Z. Tong, Yi Zheng, Lulu Liu, 2024, Cancer gene therapy.

S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function

Z. Tong, Yi Zheng, Lulu Liu, 2024, Journal of experimental & clinical cancer research : CR.

A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.

Yuzhi Jin, Xiaofei Cheng, Benfeng Li, 2024, Cancer letters.

Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells.

G. Dotti, Tao Sheng, Xinyuan Shen, 2024, Nature materials.